Quidditas Therapeutics
Pre-clinicalQuidditas Therapeutics developed an alternative technology which permits an absolute genetic recombination with a large scope of applications.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Quidditas Therapeutics developed an alternative technology which permits an absolute genetic recombination with a large scope of applications.
NeuroscienceRare Disease